Quantitative Systematic Strategies LLC Cyma Bay Therapeutics, Inc. Transaction History

Quantitative Systematic Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$1.33 - $5.93 $47,121 - $210,099	-35,430 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$5.12 - $7.21 $1,295 - $1,824	253 Added 0.72%	35,430 $181,000
Q2 2019 Jul 25, 2019	BUY	$6.05 - $13.66 $212,820 - $480,517	35,177 New	35,177 $252,000
Q1 2019 Apr 15, 2019	SELL	$8.16 - $13.42 $149,621 - $246,069	-18,336 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$6.54 - $11.74 $32,791 - $58,864	-5,014 Reduced 21.47%	18,336 $144,000
Q3 2018 Nov 14, 2018	BUY	$10.88 - $14.52 $254,048 - $339,042	23,350 New	23,350 $259,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.